After Tuesday, May 26th, you will be required to authenticate similar to VPN to access your email remotely, whether on a computer or a mobile device, such as your cell phone. This will also be required for other applications. Please go to OIT’s website for steps to take now.
You've learned a lot about the coronavirus (COVID-19) and how to keep you and your family safe. But what about the other, furrier members of the family, your pets? The U.S. Food and Drug Administration offers some questions and answers to help keep you, your family, and your pets safe during the pandemic.
The Epic report previously titled “Research Associated Participant Encounters” report (a.k.a. the “Linking Report”) has been renamed the “Clinical Research Enrolled Participant Encounters Report” (CREPE).
The new sites for Clinical Research Support (CRS) and the Office of Laboratory Animal Resources (OLAR) will be effective as of May 13, 2020. If you currently have a page from the old sites listed in your bookmarks, make sure you update them with the new URLs.
The Trial Innovation Network (TIN) is a collaborative national network within the CTSA Program to support innovation in multi-center clinical trials and studies. The vision for the TIN is to innovatively address critical roadblocks in clinical trials and accelerate the translation of novel interventions into life-saving therapies.
We are excited to share that on Wednesday, March 18 you will see a new look on several webpages that you frequently visit. Please take a moment to familiarize yourself with the new pages. We can assure you that all the previous information from the old pages will be moved into this new format.
University of Colorado and Children’s Hospital Colorado are continuing to collaborate as one team to identify areas where the existing contracting processes for child health research can be streamlined. We’re excited to announce that effective March 10, 2020, University of Colorado will be the contracting party and signatory of industry confidential disclosure agreements (CDAs).